000 01470 a2200409 4500
005 20250513031320.0
264 0 _c19950123
008 199501s 0 0 eng d
022 _a0732-183X
024 7 _a10.1200/JCO.1995.13.1.87
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aStevens, M J
245 0 0 _aPrognostic significance of early serum tumor marker half-life in metastatic testicular teratoma.
_h[electronic resource]
260 _bJournal of clinical oncology : official journal of the American Society of Clinical Oncology
_cJan 1995
300 _a87-92 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aBiomarkers, Tumor
_xblood
650 0 4 _aChorionic Gonadotropin
_xblood
650 0 4 _aChorionic Gonadotropin, beta Subunit, Human
650 0 4 _aDisease-Free Survival
650 0 4 _aHalf-Life
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aPeptide Fragments
_xblood
650 0 4 _aPrognosis
650 0 4 _aTeratoma
_xblood
650 0 4 _aTesticular Neoplasms
_xblood
650 0 4 _aalpha-Fetoproteins
_xanalysis
700 1 _aNorman, A R
700 1 _aDearnaley, D P
700 1 _aHorwich, A
773 0 _tJournal of clinical oncology : official journal of the American Society of Clinical Oncology
_gvol. 13
_gno. 1
_gp. 87-92
856 4 0 _uhttps://doi.org/10.1200/JCO.1995.13.1.87
_zAvailable from publisher's website
999 _c7527735
_d7527735